Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
0 competitors in Refractory Systemic Lupus Erythematosus
View Full LandscapeTarget Indication
Refractory Systemic Lupus Erythematosus
Clinical Trial
NCT06530849Last updated: 8/15/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Hypercholesterolemia
Healthy Japanese Children Age 2 Years Through 6 Years
Generalized Anxiety Disorder
Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer